Add like
Add dislike
Add to saved papers

Syntheses, structures and properties of two new isostructural zinc(II) complexes based on 1-[(benzotriazol-1-yl)methyl]-1H-imidazole.

Due to their strong coordination ability and the diversities of their coordination modes, N-heterocyclic organic compounds are used extensively as ligands for the construction of complexes with fascinating structures and potential applications in many fields. Two new complexes, namely bis{1-[(benzotriazol-1-yl)methyl]-1H-imidazole-κN3 }dibromidozinc(II), [ZnBr2 (C10 H9 N5 )2 ], (I), and bis{1-[(benzotriazol-1-yl)methyl]-1H-imidazole-κN3 }diiodidozinc(II), [ZnI2 (C10 H9 N5 )2 ], (II), have been synthesized by reaction of the unsymmetrical N-heterocyclic ligand 1-[(benzotriazol-1-yl)methyl]-1H-imidazole (bmi) with Zn(acetate)2 in the presence of KBr or KI. Single-crystal X-ray diffraction analysis shows that both complexes exhibit a mononuclear structure, in which the bmi ligands coordinate to the central metal ion in a monodentate mode. In the solid state, both complexes possess a three-dimensional network formed by hydrogen bonds and π-π interactions. In addition, the IR spectroscopic properties, PXRD patterns and fluorescence properties of both complexes have been investigated.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app